Please assess the completion status of the following clinical trial:

Trial Title: The Effectiveness of Megadose Shinbaro Pharmacopuncture for Patients With Chronic Shoulder Pain

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with NRS ≥ 4 for shoulder pain over 3weeks~* Patients aged 19-70 years on the date they sign the consent form.~* Patients who provide consent to participate in the trial and return the informed consent form~Exclusion Criteria:~* Patients who have been diagnosed with a severe disease that may cause shoulder pain,~* Patients with progressive neurological deficit or with serious neurological symptoms caused by spinal cord compression.~* Patients who visited a hospital in pain caused by a traffic accident.~* Patients with a severe mental illness.~* Patients who are difficult to complete the research participation agreement

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Megadose Shinbaro Pharmacopuncture Group (Type: None): The Megadose Shinbaro Pharmacopuncture group who are treated with korean medical treatment including Megadose Shinbaro Pharmacopuncture will be evaluated on first, second, third visit and 2weeks after baseline. And the patients will receive telephone inquires after 3months from the baseline.~The Korean medical treatment includes acupuncture, chuna and Korean herbal medicine.
- Control Group (Type: None): The control group who are treated with Korean medical treatment not including Megadose Shinbaro Pharmacopuncture will be evaluated on first, second, third visit and 2weeks after baseline. And the patients will receive telephone inquires after 3months from the baseline.~The Korean medical treatment includes acupuncture, chuna and Korean herbal medicine.

Based on this trial design, predict the completion outcome and termination type (if applicable).